Clinical Trial Update: Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update investigates response and biology-based risk-factor guided therapy for younger patients with non-high risk neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ganglioneuroblastoma
• Localized Resectable Neuroblastoma
• Localized Unresectable Neuroblastoma
• Neuroblastoma

Snippet

Sponsor: Children's Oncology Group | Conditions: Ganglioneuroblastoma, Localized Resectable Neuroblastoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING